Literature DB >> 15908468

Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography.

Matthew L Springer1, Richard E Sievers, Mohan N Viswanathan, Michael S Yee, Elyse Foster, William Grossman, Yerem Yeghiazarians.   

Abstract

The mouse is an important model for the development of therapeutic stem cell/bone marrow cell implantation to treat ischemic myocardium. However, its small heart size hampers accurate implantation into the left ventricular (LV) wall. Precise injections have required surgical visualization of the heart, which is subject to complications and is impractical for delayed or repeated injections. Furthermore, the thickness of the myocardium is comparable to the length of a needle bevel, so surgical exposure does not prevent inadvertent injection into the LV cavity. We describe the use of high-resolution echocardiography to guide nonsurgical injections accurately into the mouse myocardial wall. We optimized this system by using a mixture of ultrasound contrast and fluorescent microspheres injected into the myocardium, which enabled us to interpret the ultrasound image of the needle during injection. Quantitative dye injection studies demonstrated that guided closed-chest injections and open-chest injections deliver comparable amounts of injectate to the myocardium. We successfully used this system in a mouse myocardial infarction model to target the injection of labeled cells to a region adjacent to the infarct. Intentional injection of tracer into the LV cavity resulted in a small accumulation in the myocardium, suggesting that non-guided cell injections into mouse hearts may appear to be successful even if the majority of the injectate is lost in the chamber. The use of this system will allow more precise cellular implantation into the mouse myocardium by accurately guiding injections to desired locations, confirming successful implantation of cells, in a clinically relevant time frame.

Entities:  

Mesh:

Year:  2005        PMID: 15908468     DOI: 10.1152/ajpheart.00164.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  34 in total

1.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

2.  Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.

Authors:  Meenakshi Gaur; Carissa Ritner; Rich Sievers; Anissa Pedersen; Megha Prasad; Harold S Bernstein; Yerem Yeghiazarians
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

3.  Approach to assessing myocardial perfusion in rats using static [13N]-ammonia images and a small-animal PET.

Authors:  Juan José Vaquero; Dong-Wei Gao; Carmen García-Villaba; Stephen Bacharach; Henry Vanbrocklin; Qizhi Fang; Manuel Desco; Randall Lee; Michael Dae
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

4.  Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Authors:  Xiaoyin Wang; Junya Takagawa; Viola C Lam; Daniel J Haddad; Diana L Tobler; Pamela Y Mok; Yan Zhang; Brian T Clifford; Kranthi Pinnamaneni; Shereen A Saini; Robert Su; Maya J Bartel; Richard E Sievers; Larry Carbone; Scott Kogan; Yerem Yeghiazarians; Michelle Hermiston; Matthew L Springer
Journal:  Sci Transl Med       Date:  2011-09-14       Impact factor: 17.956

Review 5.  Listening for the therapeutic window: Advances in drug delivery utilizing photoacoustic imaging.

Authors:  Colman Moore; Fang Chen; Junxin Wang; Jesse V Jokerst
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

6.  Design and Evaluation of a Robotic Device for Automated Tail Vein Cannulations in Rodent Models.

Authors:  Alex Fromholtz; Max L Balter; Alvin I Chen; Josh M Leipheimer; Anil Shrirao; Timothy J Maguire; Martin L Yarmush
Journal:  J Med Device       Date:  2017-10-16       Impact factor: 0.582

7.  Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model.

Authors:  Alejandro Giraldo; Jesús Talavera López; Maria Josefa Fernandez-Del-Palacio; Obdulio García-Nicolás; Juan Seva; Gavin Brooks; José María Moraleda
Journal:  J Vis Exp       Date:  2018-01-21       Impact factor: 1.355

8.  Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes.

Authors:  Songtao An; Xiaoyin Wang; Melissa A Ruck; Hilda J Rodriguez; Dmitry S Kostyushev; Monika Varga; Emmy Luu; Ronak Derakhshandeh; Sergey V Suchkov; Scott C Kogan; Michelle L Hermiston; Matthew L Springer
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

9.  β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation.

Authors:  Mohsin Khan; Sadia Mohsin; Daniele Avitabile; Sailay Siddiqi; Jonathan Nguyen; Kathleen Wallach; Pearl Quijada; Michael McGregor; Natalie Gude; Roberto Alvarez; Douglas G Tilley; Walter J Koch; Mark A Sussman
Journal:  Circ Res       Date:  2012-12-14       Impact factor: 17.367

10.  Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

Authors:  Yerem Yeghiazarians; Yan Zhang; Megha Prasad; Henry Shih; Shereen A Saini; Junya Takagawa; Richard E Sievers; Maelene L Wong; Neel K Kapasi; Rachel Mirsky; Juha Koskenvuo; Petros Minasi; Jianqin Ye; Mohan N Viswanathan; Franca S Angeli; Andrew J Boyle; Matthew L Springer; William Grossman
Journal:  Mol Ther       Date:  2009-04-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.